Urology News and Research

Latest Urology News and Research

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.

9 May 2013

UCSF researchers find new genomic test to identify aggressive form of prostate cancer

A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.

9 May 2013

Robotic partial nephrectomy involves excessive hospital charges

Robot-assisted surgery to remove kidney cancers has seen a rapid increase in use, and has both replaced and proven safer than laparoscopic procedures for the same purpose, according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.

8 May 2013

Study: Patients are more likely to have recurrence of cancer after bladder removal

Patients with advanced bladder cancers that are surgically removed might need additional therapy to prevent recurrence in certain situations, a new UT Southwestern Medical Center study suggests.

8 May 2013

PCNL procedure to remove kidney stones in women has risen in recent years, study reveals

While the number of people - especially women - who have a minimally invasive procedure to remove kidney stones has risen in recent years, so has the rate of complications related to the surgery, according to a published study by Henry Ford Hospital in Detroit.

8 May 2013

Testing Stat5 gene amplification in prostate cancer patients could provide powerful therapy: Study

An international group of investigators, led by researchers at Thomas Jefferson University's Kimmel Cancer Center, have solved the mystery of why a substantial percentage of castrate-resistant metastatic prostate cancer cells contain abnormally high levels of the pro-growth protein Stat5.

8 May 2013

New guidelines for radiation therapy after prostatectomy

Based on a major effort co-led by Richard Valicenti, UC Davis Department of Radiation Oncology Professor and Chair, the nation's leading urological and radiation oncology organizations today announced a new guideline for radiation therapy after prostatectomy.

8 May 2013

Cost-effective endoscopic system for urological procedures launched by Cook Medical

A new, cost-effective endoscopic option is now available to urologists. Physicians can use the Flexor® Vue™ Deflecting Endoscopic System during urological procedures to access and visualize body cavities or organs.

7 May 2013

Primary health care for patients with urinary tract infections can save nearly $4 billion in ER visits

Giving patients better access to primary health care could save nearly $4 billion a year in unnecessary emergency room visits for a single common complaint - urinary tract infections - according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.

7 May 2013

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.

7 May 2013

Study: Surgeons training in robotic surgery learned best when three different teaching methods are used

By developing a new way to compare techniques for teaching robotic surgery, doctors at The Methodist Hospital and the University of Southern California report in an upcoming issue of the British Journal of Urology International that surgeons training in robotic surgery learned best when three different teaching methods were used.

6 May 2013

Incidence of testicular cancer on rise among American males

The incidence of testicular cancer has increased among American males over 15 years of age for more than 20 years and while overall incidence is still highest among Caucasian males, the greatest increase was observed in the Hispanic community, according to a new study at the 108th Annual Scientific Meeting of the American Urological Association.

5 May 2013

New clinical practice guideline for prostate cancer screening released at 2013 AUA Annual Meeting

Men ages 55 to 69 who are considering prostate cancer screening should talk with their doctors about the benefits and harms of testing and proceed based on their personal values and preferences, according to a new clinical practice guideline released today by the American Urological Association.

5 May 2013

Study estimates ER costs for hematuria patients at more than $237 million a year

A relatively common urinary tract disorder that can usually be managed in an outpatient setting is adding an estimated $238 million a year to the cost of emergency room visits in the U.S., according to two new studies from Henry Ford Hospital in Detroit.

5 May 2013

Laparoscopic radical nephropathy effective for advanced renal masses

Laparoscopic radical nephrectomy is an effective treatment approach for individuals with renal cell carcinoma who have larger or more advanced renal masses, report researchers.

29 Apr 2013

New risk classification system proposed for prostate cancer

US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy.

29 Apr 2013

Hypertensive patients may need firm dietary advice

People who have dyslipidemia or are overweight adopt healthier diets than those without, whereas patients with hypertension persist with some unhealthy eating patterns, study results show.

29 Apr 2013

Absorption Pharmaceuticals to obtain patent for Promescent medication

Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation.

29 Apr 2013

Actavis resolves patent litigation related to generic version of INTUNIV for treatment of ADHD

Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.

26 Apr 2013

New risk classification system proposed for prostate cancer

US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy.

25 Apr 2013

Urology News and Research

Latest Urology News and Research

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

UCSF researchers find new genomic test to identify aggressive form of prostate cancer

Robotic partial nephrectomy involves excessive hospital charges

Study: Patients are more likely to have recurrence of cancer after bladder removal

PCNL procedure to remove kidney stones in women has risen in recent years, study reveals

Testing Stat5 gene amplification in prostate cancer patients could provide powerful therapy: Study

New guidelines for radiation therapy after prostatectomy

Cost-effective endoscopic system for urological procedures launched by Cook Medical

Primary health care for patients with urinary tract infections can save nearly $4 billion in ER visits

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

Study: Surgeons training in robotic surgery learned best when three different teaching methods are used

Incidence of testicular cancer on rise among American males

New clinical practice guideline for prostate cancer screening released at 2013 AUA Annual Meeting

Study estimates ER costs for hematuria patients at more than $237 million a year

Laparoscopic radical nephropathy effective for advanced renal masses

New risk classification system proposed for prostate cancer

Hypertensive patients may need firm dietary advice

Absorption Pharmaceuticals to obtain patent for Promescent medication

Actavis resolves patent litigation related to generic version of INTUNIV for treatment of ADHD

New risk classification system proposed for prostate cancer

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Urology News and Research

Latest Urology News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in